[Microbial spectrum of nosocomial pneumonia in traumatological patients]

N Avazashvili1, T Nozadze, D Chikviladze

  • 1Department of Traumatology and Orthopedics, Tbilisi State Medical University, Georgia.

Georgian Medical News
|June 21, 2011
PubMed

Insights

Nosocomial pneumonia in trauma patients is often caused by multiple microbes, including Staphylococcus aureus and Klebsiella pneumoniae. High antibiotic resistance, including pan-resistance, necessitates targeted antimicrobial therapy based on microbial susceptibility testing.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Clinical Medicine

Background:

  • Nosocomial pneumonia is a significant complication in hospitalized patients, particularly those undergoing orthopedic procedures.
  • Understanding the microbial etiology and antibiotic resistance patterns is crucial for effective treatment.

Purpose of the Study:

  • To investigate the microbiological agents and antibiotic resistance profiles of nosocomial pneumonia in traumatological patients.
  • To determine the prevalence of different microbial structures and their susceptibility to various antibiotics.

Main Methods:

  • Microbiological investigation of 727 traumatological patients with hip replacement or limb osteosynthesis.
  • Isolation and identification of microbial strains from 27 cases of nosocomial pneumonia.
  • Antibiotic susceptibility testing of isolated microbial strains.

Main Results:

  • Nosocomial pneumonia was diagnosed in 3.7% of patients (27 cases).
  • A total of 66 microbial strains were isolated, with polymicrobial infections (85.2%) being more common than monomicrobial infections (14.8%).
  • Key pathogens identified include Staphylococcus aureus (27.3%), Klebsiella pneumoniae (19.7%), Streptococcus pneumoniae (15.2%), Acinetobacter baumannii (10.6%), and Pseudomonas aeruginosa (13.6%).
  • High levels of antibiotic resistance and pan-resistance were observed among the isolated strains.

Conclusions:

  • The study highlights the significant challenge posed by antibiotic-resistant pathogens in nosocomial pneumonia among trauma patients.
  • Prompt and accurate antibiotic selection based on etiological diagnosis and susceptibility testing is critical for successful antimicrobial therapy.
  • Empirical treatment should consider broad-spectrum agents like carbapenems, with linezolid or vancomycin recommended for suspected MRSA infections.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...